SCHEMBL7658973

SCHEMBL7658973

CCOC(=O)/C(=C\N(C)C)C(=O)c1cc(F)c(Cl)c(C#N)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.41
CYP11B1 P15538 11/20 0.40
CYP11B2 P19099 7/20 0.38
GPR35 Q9HC97 1/20 0.38
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
STAT3 P40763 1/20 0.35
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615300 1.00 CYP2C9 (0.41) CYP2C9CYP11B1CYP11B2GPR35MAPT
SCHEMBL9475692 0.86 GPR35 (0.39) CYP2C9GPR35MAPTKDM4EALDH1A1
SCHEMBL9475695 0.86 GPR35 (0.39) CYP2C9GPR35MAPTKDM4EALDH1A1
SCHEMBL9475701 0.86 GPR35 (0.39) CYP2C9GPR35MAPTKDM4EALDH1A1
SCHEMBL7486003 0.84 CYP2C9 (0.43) CYP2C9CYP11B1CYP11B2MAPTKDM4E
SCHEMBL7654922 0.84 CYP2C9 (0.43) CYP2C9CYP11B1CYP11B2MAPTKDM4E
SCHEMBL9562415 0.80 CYP2C9 (0.40) CYP2C9CYP11B1CYP11B2GPR35MAPT
SCHEMBL9212344 0.80 CYP2C9 (0.40) CYP2C9CYP11B1CYP11B2GPR35MAPT
SCHEMBL5704344 0.80 GPR35 (0.37) CYP2C9GPR35MAPTKDM4EALDH1A1
SCHEMBL5704342 0.80 GPR35 (0.37) CYP2C9GPR35MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432948-B1 ANTIULCER AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2002-08-13 US disclosed
US-6133260-A Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases BAYER AKTIENGESELLSCHAFT (DE) 2000-10-17 US disclosed